India Q2 FY27 Earnings Season: Mid-Cap Growth Stories Deliver Broad Beats Across Construction, Tech, and Pharma

The Quick Take

• PSP Projects posts record quarterly revenue of ₹1,113 crore, up 58% YoY, with a ₹12,870 crore order book.
• Syrma SGS Technology delivers 71% H1 FY27 revenue growth with a ₹7,420 crore order backlog.
• Multiple Indian mid-caps across construction, electronics manufacturing, and pharma beat consensus in Q2 FY27.

India's Q2 FY27 earnings season, covering the July-September 2026 quarter, is delivering an unusually broad set of positive surprises from mid-cap and small-cap companies across diverse sectors. PSP Projects—an infrastructure and construction company—sets the tone with a record quarterly revenue of ₹1,113 crore (58% year-on-year growth) and an order book of ₹12,870 crore that provides strong forward revenue visibility. The result reflects the sustained momentum in government capital expenditure programs for highways, urban infrastructure, and energy projects that has been a cornerstone of India's growth strategy under the current administration, and the company's execution track record on project delivery timelines has earned it preferred contractor status across multiple state governments.

In the technology manufacturing sector, Syrma SGS Technology's 71% H1 FY27 revenue growth and a ₹7,420 crore order backlog signal that India's electronics manufacturing push under Production Linked Incentive schemes is generating real commercial traction. Syrma, which provides electronics manufacturing services for defense, industrial, and consumer electronics clients, is benefiting from both the domestic government's indigenization mandate and the global supply chain diversification trend that is directing contract manufacturing orders away from China. The company's ability to convert this structural tailwind into actual revenue—confirmed by both the top-line growth and the backlog expansion—suggests the PLI strategy is achieving its intended supply-chain development objectives at a faster pace than skeptics expected.

The breadth of Q2 FY27 earnings beats across Indian mid-caps—spanning Updater Services (11% revenue growth, 62% PAT growth), Wonderla Holidays (45% revenue growth, 90% EBITDA surge), Ganesha Ecosphere (record H1 EBITDA in plastics recycling), and multiple pharmaceutical companies growing prescription drug revenues—paints a picture of an economy where multiple growth engines are firing simultaneously. For investors navigating Indian equity markets, the earnings season data argues for continued mid-cap and small-cap exposure with selective sector concentration, particularly in infrastructure execution, electronics manufacturing services, and specialty pharmaceuticals—three areas where India's structural competitive advantages are most clearly translating into corporate earnings.

Sources: GuruFocus (gurufocus.com) | Analysis by market.news AI